The extent of neuroinflammation in ALS patients is associated with a decrease in the number of Tregs and decreased FoxP3 mRNA resulting in disease progression and lower survival chances in ALS murine models and in humans with ALS. Here, FOXP3 is linked to amyotrophic lateral sclerosis.